Related Experiment Video
Updated: Aug 2, 2026

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
Effect of selegiline on speech performance in Parkinson's disease
B R Shea1, S S Drummond, W S Metzer
1University of Arkansas for Medical Sciences, Little Rock.
Abstract:
Comprehensive speech examinations of 10 equally affected subjects with moderate, treated Parkinson's disease were performed before and 4 weeks following initiation of treatment with selegiline (deprenyl), with other drug therapies unchanged. Forty different measures relating to the speech processes of respiration, phonation, resonation, articulation and prosody were examined to measure changes in performance due to selegiline. Significant improvements were noted for 8 of the 40 measures, with these improvements relating to the speech processes of articulation and respiration. The potential interactive effects of comedication are discussed. In addition, previously undescribed comprehensive speech characteristics of moderate Parkinson's disease are presented and discussed.
Related Concept Videos
Neural Regulation
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction
Parkinson Disease ll: Pathophysiology
Alterations in Muscle Tone lll

